86% Reduction in Re-Operations: Abstract Presented at SESPRS
Exciting news! An abstract was presented at the SESPRS 69th Annual Scientific Meeting showing that the use of the SOMAVAC internal negative pressure wound therapy device was associated…
Exciting news! An abstract was presented at the SESPRS 69th Annual Scientific Meeting showing that the use of the SOMAVAC internal negative pressure wound therapy device was associated…
We are pleased to welcome Joe Adam as our new Chief Operating Officer! Joe is an accomplished medical device and semiconductor executive with decades of experience leading operations, strategy, and…
We’re honored to be featured in The Lens Magazine, by LSI’s Alumni Innovator Spotlight, highlighting how SOMAVAC®, under the leadership of CEO Elizabeth Hoff, is revolutionizing one of…
Modernizing surgical recovery with a proven solution that shortens drain duration, simplifies care, and improves satisfaction for patients and providers alike. Fifty years without innovation Surgical drainage is…
A white paper by Jane Berz, MSN, RN, FNCBC, Chair of the Board, SOMAVAC® Medical Solutions, Inc. Highlights below; the complete paper is available as a PDF. Read…
We are pleased to welcome Frankie Mead as our new VP of Sales! Frankie comes to us with 25 years of sales leadership expertise in the plastic surgery…
At the core of LSI’s Emerging Medtech Summits are our innovators. This year, 362 early and growth-stage companies took the stage to share how their technologies aim to…
Under the direction of CEO Elizabeth Hoff, SOMAVAC is challenging the status quo of post-surgical care with its innovative negative pressure solutions. By improving the patient experience and…
SOMAVAC® presenting at the 13th Annual Texas Life Science Forum, co-hosted by BioHouston and Rice Alliance, is Texas’ premier life science and health-tech event, taking place on November…
There was strong recognition at ASPS that seroma mitigation and elimination are essential to transforming outcomes for breast reconstruction patients. Attendees were particularly excited by SOMAVAC’s FDA-cleared technology.